Highlight • Five gut microbiota were found to be causally associated with bladder cancer. • Among these taxa, the genus Bilophila was identified as having a promoting effect on bladder…
Highlights • We compared treatments in patients with cT1 renal masses undergoing immediate vs delayed intervention. • Use of nephron sparing interventions were not compromised by a period of active…
Highlights • Overweight patients with metastatic renal cell carcinoma had an overall survival advantage following first-line therapies. • Obesity paradox may exist in the contemporary cancer immunotherapy era for metastatic…
Highlights • Largest single tertiary center RARC series with the longest follow-up in the U.S. • Extravesical disease and lymph node positivity affect OS and RFS long-term. • Infection and…
Highlights • Suture-free PN is a safe and feasible technique for T1a renal masses. • Suture-free PN benefits short-term and long-term SRF and eGFR compared to conventional Suture PN. Abstract…
Highlights • Micropapillary Urothelial Carcinoma (MPUC) is associated with poor oncologic outcomes. • Unknown whether greater fraction of MPUC component is prognostically relevant. • Largest ever pathologic review and quantification…
Highlights • The effect of 5-alpha reductase inhibitors on upper tract urothelial carcinoma has not been explored. • Men taking 5-alpha reductase inhibitors were identified using Merative TM Marketscan®. •…
Highlights • Mean medical care costs in the year following radical cystectomy were similar between bladder cancer patients who received an ileal conduit and those who received a neobladder. •…
Highlights • Biopsy (RTB) is an optional tool during decision making for renal cancer. • The discordance between biopsy and final surgical pathology is minimal. • The optimal RTB should…
Highlights • The microbiome plays critical roles in immune response to cancer. • Broader efforts are needed to better define the gut and urinary microbiomes. • Microbial metabolites can modulate…
